Trulieve Cannabis Corp. TRLV
11.21 USD +0.31 (+2.84%)
Nov 6, 2026, 10:28 AM EST
10.77 Day range 11.31
4.62 52-week range 13.28
- YTD
- +29.00%
- 1 year
- +79.65%
Financial health
Altman Z-Score
0.29 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 3
Valuation
P/E -14.2×
FY 2025 5y median -14.2× FY 2025
P/S 1.4×
FY 2025 5y median 1.4× FY 2025
P/B 1.4×
FY 2025 5y median 1.4× FY 2025
P/FCF 7.8×
FY 2025 5y median 7.8× FY 2025
EV/EBITDA 6.0×
FY 2025 5y median 6.0× FY 2025
EV/Sales 1.7×
FY 2025 5y median 1.7× FY 2025
FCF Yield 12.8%
FY 2025 5y median 12.8% FY 2025
Profitability
Gross Margin 60.2%
FY 2025 5y median 60.2% FY 2025
Operating Margin 12.6%
FY 2025 5y median 12.6% FY 2025
Net Margin -9.9%
FY 2025 5y median -9.9% FY 2025
ROE -10.0%
FY 2025 5y median -10.0% FY 2025
ROIC -7.3%
FY 2025 5y median -7.3% FY 2025
ROA -4.3%
FY 2025 5y median -4.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 4.4×
FY 2025 5y median 4.4× FY 2025
Quick Ratio 2.5×
FY 2025 5y median 2.5× FY 2025
Debt / Equity 0.5×
FY 2025 5y median 0.5× FY 2025
Net Debt / EBITDA 0.9×
FY 2025 5y median 0.9× FY 2025
Interest Coverage 2.3×
FY 2025 5y median 2.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31